Catherine Turkel
Direktor/Vorstandsmitglied bei LEXARIA BIOSCIENCE CORP.
Vermögen: 3 285 $ am 30.04.2024
Profil
Catherine C.
Turkel is an Independent Director at Lexaria Bioscience Corp.
and the Prostate Cancer Research Institute.
She previously worked as the Director of Drug Development & Regulatory Affairs at Cypros Pharmaceutical Corp., Vice President of Clinical Development at Allergan, Inc., Chief Development Officer at Otic Pharma Ltd., and President at Eledon Pharmaceuticals, Inc. Turkel holds an MBA from the University of California, Irvine, and doctorates from the University of the Pacific and Capella University LLC.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LEXARIA BIOSCIENCE CORP.
0,01% | 26.04.2024 | 1 500 ( 0,01% ) | 3 285 $ | 30.04.2024 |
Aktive Positionen von Catherine Turkel
| Unternehmen | Position | Beginn |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | Direktor/Vorstandsmitglied | 02.09.2022 |
| Prostate Cancer Research Institute | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Catherine Turkel
| Unternehmen | Position | Ende |
|---|---|---|
Object Pharma, Inc.
 Object Pharma, Inc. BiotechnologyHealth Technology Object Pharma, Inc developing botulinum neurotoxins for unmet needs in aesthetic and therapeutic markets. The company is headquartered in New Port Beach, California. | Direktor/Vorstandsmitglied | 01.04.2023 |
| ELEDON PHARMACEUTICALS, INC. | Präsident | 30.06.2020 |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01.01.2017 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01.01.2015 |
| Cypros Pharmaceutical Corp. | Corporate Officer/Principal | 01.01.1998 |
Ausbildung von Catherine Turkel
| University of California, Irvine | Masters Business Admin |
| University of the Pacific | Doctorate Degree |
| Capella University LLC | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LEXARIA BIOSCIENCE CORP. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
| Cypros Pharmaceutical Corp. | Health Technology |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
| Prostate Cancer Research Institute | |
Object Pharma, Inc.
Object Pharma, Inc. BiotechnologyHealth Technology Object Pharma, Inc developing botulinum neurotoxins for unmet needs in aesthetic and therapeutic markets. The company is headquartered in New Port Beach, California. | Health Technology |
